Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals Telephone: +1 (800) 910-6452 Mail at: sales@researchbeam.com
Report Overview “Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals� report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2015. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data presented in this report is derived from proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research. Scope - Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments. - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry. Strategic Focus Report @ http://www.researchbeam.com/partnerships-licensing-investments-and-manda-deals-and-trends-for2015-in-pharmaceuticals-market
Report Overview - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As. - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry. - Analysis of partnership and licensing deals based on clinical stage of development of products. - Summary of the pharmaceutical deals globally in the last five years. - Information on the top deals happened in the pharmaceutical industry. Reasons to Buy - Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry. - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets. - Identify companies that are aggressively looking to raise capital in the market - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry. - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies. - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
Table of Contents 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 12 2 Pharmaceutical & Healthcare, Global, Deals Summary 18 2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2015 18 2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2015 by Quarter 20 2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2015 22 2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2015 23 2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2015 24 2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2015 25 2.5.1 Allergan and Pfizer to Combine in USD160 Billion Deal 25 2.5.2 Teva Pharma to Acquire Generics Drug Business from Allergan for USD40.5 Billion 26 2.5.3 Actavis Raises USD21 Billion in Public Offering of Senior Notes 27 2.5.4 AbbVie Acquires Pharmacyclics 28 2.5.5 Pfizer Acquires Hospira for USD17 Billion 29 2.5.6 Danaher Acquires Pall for USD13.8 Billion 30 2.5.7 CVS Health Acquires Omnicare for USD12.9 Billion 31 2.5.8 UnitedHealth Acquires Catamaran for USD12.8 Billion 32 2.5.9 Valeant Pharma Acquires Salix Pharma for USD10.9 Billion 32 2.5.10 AbbVie Raises USD16.7 Billion in Public Offering of Notes 34 3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2015 35 4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 36
Table of Contents 5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 91 5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2015 91 5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2015 by Quarter 93 5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2015 98 5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2015 by Quarter 100 5.2.2 Central Nervous System - Deals of the Year 101 5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2015 106 5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2015 by Quarter 108 5.3.2 Infectious Disease - Deals of the Year 109 6 Pharmaceuticals & Healthcare, Deal Summary, By Geography 137 6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2015 137 6.1.2 North America - Deals of the Year 140 6.2 Pharmaceuticals & Healthcare, European Region Deals, 2015 146 6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2015 by Quarter 148 6.2.2 Europe - Deals of the Year 149 6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2015 by Quarter 139 7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2015 166 7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2015 168 8 Further Information 170 8.1 Methodology 170 8.2 About GlobalData 171 8.3 Disclosure information 171
Report Ordering
Report Name: Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals Product Price User
Price
Single User
US $ 2975
Site User
US $ 7000
Global User
US $ 10500
To View Sample or Purchase Report
Contact Us
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/partnerships-licensing-investments-and-manda-deals-and-trends-for2015-in-pharmaceuticals-market
Stay With Us At:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States